IP Library Assignment 030711/0477
Patent Assignment
Reel/Frame 030711/0477

Assignment of Assignor's Interest

Recorded: 2013-06-28 Pages: 8
Assignor
ABBOTT GMBH & CO KG
Executed: 2012-11-01
Assignee
ABBVIE DEUTSCHLAND GMBH & CO KG
MAX-PLANCK-RING 2A, WIESBADEN, 65205, GERMANY
Covered Properties (63)
1-Amino-3-Phenoxy Propane Derivatives as Modulator Agents and Their Applications
Patent: 5,622,953 →
Application: 08/468,630 →
Novel Thrombin-Inhibitory Protein from Ticks
Patent: 5,827,731 →
Application: 08/859,183 →
Automatic Pipetting Apparatus
Patent: 6,234,033 →
Application: 09/301,578 →
Ketobenzamides as Calpain Inhibitors
Patent: 6,103,720 →
Application: 09/319,511 →
Method for Producing Aromatic Bisimides
Patent: 6,177,570 →
Application: 09/381,051 →
Process for Producing Coated Solid Dosage Forms
Patent: 6,350,398 →
Application: 09/385,459 →
Test System for Characterizing the Compatibility of Bioactive Substances and Polyvinyipyrrolidone
Patent: 6,599,931 →
Application: 09/396,363 →
Process for Producing Solid Dosage Forms
Patent: 6,423,256 →
Application: 09/417,070 →
Method for Producing Small-Particle Preparations of Biologically Active Substances
Patent: 6,318,650 →
Application: 09/424,513 →
3-Substituted Pyrido [3',4':4,5] Thieno [2,3-D] Pyrimidine Derivatives, and Production and Use of the Same
Patent: 6,159,981 →
Application: 09/445,178 →
3-Substituted 3,4 Dihydro-Thieno[2,3-D]Pyrimidine Derivatives and Production and Use of the Same
Patent: 6,159,962 →
Application: 09/445,222 →
Triazole Compounds and the Use Thereof as Dopamine-D3-Ligands
Patent: 6,472,392 →
Application: 09/446,520 →
Ancrod Specific Monoclonal Antibodies, Antibody Fragments, Mixtures or Derivatives Thereof and Use of the Same
Patent: 6,365,155 →
Application: 09/446,983 →
3-Substituted 3,4,5,7-Tetrahydro-PYRROLO3',4'4,5 THIENO2,3-Dpyrimidine Derivatives, Their Preparation and Use as 5HT Antagonists
Patent: 6,355,647 →
Application: 09/485,188 →
3-Substituted Tetrahydropyridopyrimidinone Derivatives, Method for Producing the Same, and Their Use
Patent: 6,414,157 →
Application: 09/529,231 →
2-Substituted 1,2-Benzisothiazole Derivatives and Their Use as Serotonin Antagonists (5-HT1A, 5HT1B and 5-HT1D)
Patent: 6,346,622 →
Application: 09/529,828 →
Low Molecular Weight Inhibitors of Complement Proteases
Patent: 6,683,055 →
Application: 09/539,811 →
Salts of Thrombin Inhibitors
Patent: 6,407,067 →
Application: 09/559,047 →
Thrombin Inhibitors
Patent: 6,740,647 →
Application: 09/582,040 →
Heterocyclically Substituted Amides Used as Calpain Inhibitors
Patent: 6,562,827 →
Application: 09/647,681 →
Novel Heterocyclically Substituted Benzamides and Their Use
Patent: 6,436,949 →
Application: 09/666,304 →
Novel Heterocyclically Substituted Amides, Their Preparation and Use
Patent: 6,630,493 →
Application: 09/673,087 →
Novel Substituted Amides, Their Preparation and Use
Patent: 6,753,327 →
Application: 09/673,089 →
Heterocyclically Substituted Amides, Their Production and Their Use
Patent: 6,482,832 →
Application: 09/700,453 →
Poly(Adp-Ribose)Polymerase-Gene
Patent: 7,754,459 →
Application: 09/701,586 →
N-substituted azabicycloheptane derivatives, production and use thereof
Patent: 6,300,354 →
Application: 09/744,405 →
N-Substituted Azabicycloheptane Derivatives, Production and Use Thereof
Patent: 6,458,821 →
Application: 09/762,046 →
Method for producing (+)-exo-6-phenyl-3-azabicyclo-[3.2.0]heptanes
Patent: 6,328,855 →
Application: 09/807,218 →
Method for Racemate Splitting of 2-Hydroxypropionic Acids
Patent: 6,559,338 →
Application: 09/830,348 →
Substituted 2-Phenylbenzimidazoles, the Production Thereof and Their Use
Patent: 7,781,596 →
Application: 09/830,992 →
2-Phenylbenzimidazoles and 2-Phenylindoles, and Production and Use Thereof
Patent: 6,509,365 →
Application: 09/856,036 →
Substituted Benzimidazoles and Their Use as Parp Inhibitors
Patent: 6,448,271 →
Application: 09/856,686 →
Nanoparticulate Core Shell Systems and the Use Thereof in Pharmaceutical and Cosmetic Preparation
Patent: 7,687,071 →
Application: 09/857,480 →
Method for Producing (2S,4R,9S) -Octahydro-1H-Indole-2-Carboxylic Acid and Intermediate Products Therefor
Patent: 6,559,318 →
Application: 09/869,651 →
Triazole Compounds with Dopamine-D3-Receptor Affinity
Patent: 6,579,892 →
Application: 09/889,156 →
Use of 5-HT5-Ligands in the Treatment of Neurodegenerative and Neuropsychiatric Disturbances
Patent: 6,750,221 →
Application: 09/889,157 →
Triazole Compounds with Dopamine-D3-Receptor Affinity
Patent: 6,602,867 →
Application: 09/889,161 →
Triazole Compounds with Dopamine-D3-Receptor Affinity
Patent: 6,583,166 →
Application: 09/889,163 →
Mechanically Stable Pharmaceutical Presentations Form Containing Liquid or Semi-Solid Surface-Active Substances
Patent: 6,599,528 →
Application: 09/936,349 →
Method of Producing 3,4-Dehydroprolines and 3,4-Dehydropiperidines
Patent: 6,579,971 →
Application: 09/937,312 →
Prodrugs of Thrombin Inhibitors
Patent: 7,144,902 →
Application: 09/958,349 →
Integrin Receptor Ligands
Patent: 7,125,883 →
Application: 09/958,491 →
Cyclo-Alkyl Substituted Benzimidazoles and Their Use as Parp Inhibitors
Patent: 6,737,421 →
Application: 09/959,161 →
Use of Phthalazine Derivatives
Patent: 6,903,098 →
Application: 09/959,404 →
Heterocyclically Substituted Benzimidazoles, the Production and Application Thereof
Patent: 6,696,437 →
Application: 09/959,632 →
Spray Drying of Thrombin Inhibitors
Patent: 6,693,120 →
Application: 09/959,786 →
Dopamine D3 Receptor Ligands or Antagonists for Use in the Treatment of Renal Function Disorders
Patent: 7,098,214 →
Application: 09/959,787 →
Method for Producing 2-Aminomethyl-4-Cyano-Thiazol
Patent: 6,642,388 →
Application: 10/031,700 →
Method for Producing 4-Cyano-2-Aminomethylthiazol
Patent: 6,639,081 →
Application: 10/031,703 →
2-{3-[4-(2-T-Butyl-6-Trifluoromethyl-4-Pyrimidinyl)-1- Piperazinyl] Propylthio}-4-Pyrimidinol Fumarate
Patent: 6,486,162 →
Application: 10/039,974 →
Publication: US 2002/0143179
Novel Integrin Receptors Antagonists
Patent: 7,105,508 →
Application: 10/049,266 →
Method of Producing 2-Hydroxycarboxylic Acid Esters
Patent: 6,646,152 →
Application: 10/070,759 →
Method for the Enantioselective Preparation of 3,3-Diphenyl-2,3-Epoxy Propionic Acid Esters
Patent: 6,677,465 →
Application: 10/181,457 →
Publication: US 2003/0162982
Heterocyclic Compounds and Their Use as Parp Inhibitors
Patent: 7,041,675 →
Application: 10/182,532 →
Publication: US 2003/0134843
Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system
Application: 10/239,828 →
Publication: US 2003/0087917
Novel Substituted Amides, Their Preparation and Use
Patent: 7,276,500 →
Application: 10/690,400 →
Publication: US 2004/0082569
Use of binding partners for 5-HT5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders
Application: 10/836,349 →
Publication: US 2004/0202656
Substituted Benzimidazoles and Their Use as Parp Inhibitors
Patent: 39,608 →
Application: 10/935,683 →
Use of Dopamine D3 Receptor Ligands for the Production of Drugs for Treating Renal Function Disorders
Patent: 8,785,447 →
Application: 11/424,739 →
Publication: US 2006/0223793
Novel Substituted Amides, Their Preparation and Use
Patent: 7,956,093 →
Application: 11/897,057 →
Publication: US 2008/0113989
Novel Poly(Adp-Ribose) Polymerase Genes
Patent: 9,051,553 →
Application: 12/778,692 →
Publication: US 2011/0107444
Novel Substituted Amides, Their Preparation and Use
Application: 12/915,680 →
Publication: US 2011/0275615
Use of Binding Partners for 5-HT5 Receptors for the Treatment of Neurodegenerative and Neuropsychiatric Disorders
Application: 13/296,433 →
Publication: US 2012/0196301
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 28, 2012
From: BASF SE
To: ABBOTT GMBH & CO. KG
Reel/Frame 028860/0620 →
Change of Name Aug 28, 2012
From: BASF AKTIENGESELLSCHAFT
To: BASF SE
Reel/Frame 028863/0971 →